Immunological Tolerance

Similar documents
Objectives. Abbas Chapter 11: Immunological Tolerance. Question 1. Question 2. Question 3. Definitions

SEVENTH EDITION CHAPTER

Lecture outline. Immunological tolerance and immune regulation. Central and peripheral tolerance. Inhibitory receptors of T cells. Regulatory T cells

Central tolerance. Mechanisms of Immune Tolerance. Regulation of the T cell response

Mechanisms of Immune Tolerance

Tolerance 2. Regulatory T cells; why tolerance fails. Abul K. Abbas UCSF. FOCiS

Determinants of Immunogenicity and Tolerance. Abul K. Abbas, MD Department of Pathology University of California San Francisco

Tolerance 2. Regulatory T cells; why tolerance fails. FOCiS. Lecture outline. Regulatory T cells. Regulatory T cells: functions and clinical relevance

Topic (Final-03): Immunologic Tolerance and Autoimmunity-Part II

FOCiS. Lecture outline. The immunological equilibrium: balancing lymphocyte activation and control. Immunological tolerance and immune regulation -- 1

Immune Regulation and Tolerance

Topic (Final-02): Immunologic Tolerance

Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF

Autoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens

What is Autoimmunity?

What is Autoimmunity?

Immune Tolerance. Kyeong Cheon Jung. Department of Pathology Seoul National University College of Medicine

Immune responses in autoimmune diseases

S. No Topic Class No Date

Autoimmunity Origins. Horror autotoxicus: Literally, the horror of self-toxicity.

T Lymphocyte Activation and Costimulation. FOCiS. Lecture outline

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:

Self Tolerance and MHC Restriction. Dr. Issa Abu-Dayyeh

Allergy and Immunology Review Corner: Chapter 19 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD.

Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells

DISCLOSURE. Relevant relationships with commercial entities none. Potential for conflicts of interest within this presentation none

Disruption of Healthy Tissue by the Immune Response Autoimmune diseases: Inappropriate immune response against self-components

T Cell Activation, Costimulation and Regulation

This is a free sample of content from Immune Tolerance. Click here for more information or to buy the book.

Autoimmune diseases. Autoimmune diseases. Autoantibodies. Autoimmune diseases relatively common

Autoimmunity. By: Nadia Chanzu, PhD Student, UNITID Infectious Minds Presentation November 17, 2011

5/1/13. The proportion of thymus that produces T cells decreases with age. The cellular organization of the thymus

DNA vaccine, peripheral T-cell tolerance modulation 185

Self-tolerance. Lack of immune responsiveness to an individual s own tissue antigens. Central Tolerance. Peripheral tolerance

The development of T cells in the thymus

Immunology Lecture 4. Clinical Relevance of the Immune System

T cell maturation. T-cell Maturation. What allows T cell maturation?

Darwinian selection and Newtonian physics wrapped up in systems biology

Primer on Tumor Immunology. International Society for Biological Therapy of Cancer. C. H. June, M.D. November 10, 2005

Immune tolerance. Lu,Linrong Institute of Immunology, ZJU

Cellular Pathology of immunological disorders

Autoimmunity. Mark S. Anderson, MD, PhD University of California San Francisco

Regulatory T Cells and Maintenance of Tolerance

Adaptive immune responses: T cell-mediated immunity

T Cell Receptor & T Cell Development

Defensive mechanisms include :

Autoimmunity & Transplantation. Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:

Effector T Cells and

CELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.

Principles of Adaptive Immunity

Diseases of Immunity 2017 CL Davis General Pathology. Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc.

Immunology for the Rheumatologist

CHAPTER 9 BIOLOGY OF THE T LYMPHOCYTE

The Adaptive Immune Response. T-cells

Immunodermatology. Danielle Tartar, MD, PhD Assistant Clinical Professor Co-Director of Inpatient Dermatology University of California - Davis

Major Histocompatibility Complex (MHC) and T Cell Receptors

Development of B and T lymphocytes

An Update On Autoimmune Diseases

LESSON 2: THE ADAPTIVE IMMUNITY

Discover the PD-1 pathway and its role in cancer 105/15 -ONCO- 07/15

Follicular Lymphoma. ced3 APOPTOSIS. *In the nematode Caenorhabditis elegans 131 of the organism's 1031 cells die during development.

Adaptive (acquired) immunity. Professor Peter Delves University College London

Immunology 2011 Lecture 20 Autoimmunity 18 October

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS

The Adaptive Immune Responses

Mucosal Immune System

General Overview of Immunology. Kimberly S. Schluns, Ph.D. Associate Professor Department of Immunology UT MD Anderson Cancer Center

The Major Histocompatibility Complex (MHC)

T Cell Effector Mechanisms I: B cell Help & DTH

[AUTOIMMUNITY] July 14, 2013

Exploiting antigen specific approaches to induce tolerance in Type 1 Diabetes

AUTOIMMUNITY CLINICAL CORRELATES

AUTOIMMUNITY TOLERANCE TO SELF

HLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol

ACTIVATION OF T LYMPHOCYTES AND CELL MEDIATED IMMUNITY

Tumor Microenvironment and Immune Suppression

Overview B cell development T cell development

Immunity and Cancer. Doriana Fruci. Lab di Immuno-Oncologia

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT

the HLA complex Hanna Mustaniemi,

T cell and Cell-mediated immunity

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

TCR, MHC and coreceptors

T cell and Cell-mediated immunity

Immunology. T-Lymphocytes. 16. Oktober 2014, Ruhr-Universität Bochum Karin Peters,

Guarding the immune system: Suppression of autoimmunity by CD4 1 CD25 1 immunoregulatory T cells

HLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol

Attribution: University of Michigan Medical School, Department of Microbiology and Immunology

Basic Immunology. Immunological tolerance. Cellular and molecular mechanisms of the immunological tolerance. Lecture 23 rd

SINGLE CHOICE. 5. The gamma invariant chain binds to this molecule during its intracytoplasmic transport. A TCR B BCR C MHC II D MHC I E FcγR

Advances in Cancer Immunotherapy

Tumor Immunity and Immunotherapy. Andrew Lichtman M.D., Ph.D. Brigham and Women s Hospital Harvard Medical School

CTLA-4 regulates pathogenicity of antigen-specific autoreactive T cells by cell-intrinsic and -extrinsic mechanisms

Immune response. This overview figure summarizes simply how our body responds to foreign molecules that enter to it.

The T cell receptor for MHC-associated peptide antigens

Tumors arise from accumulated genetic mutations. Tumor Immunology (Cancer)

Cancer immunity and immunotherapy. General principles

Antibody-Cytokine- Autoimmune

Significance of the MHC

Transcription:

Immunological Tolerance

Introduction Definition: Unresponsiveness to an antigen that is induced by exposure to that antigen Tolerogen = tolerogenic antigen = antigen that induces tolerance

Important for several reasons Self-tolerance May be used for: -autoimmune diseases -allergic diseases -transplantation -gene therapy

Experiments Peter Medawar et al. 1950s Visit http://broughttolife.sciencemuseum.org.uk/broughttolife/people/petermedawar for references

Self-tolerance Central Peripheral

Robbins and Cotran pathologic basis of disease 9 th edition

Central tolerance Immature self-reactive T or B cells In generative lymphoid organs It is not known why high-affinity binding to self antigens induces apoptosis rather than activation/proliferation

Peripheral tolerance Not all self antigens may be present in the thymus, and hence T and B cells bearing receptors for such autoantigens escape into the periphery -Anergy -Suppression by Tregs -Deletion by apoptosis These mechanisms are best defined for T cells, especially CD4+

Anergy = functional unresponsiveness Activation of antigen-specific T cells requires two signals: recognition of peptide antigen in association with self MHC molecules on the surface of APCs and a set of costimulatory signals ( second signals ) from APCs By binding of molecules on T cells to their ligands (the costimulators B7-1 and B7-2) on APCs

Anergy, cont d On resting dendritic cells in normal tissues costimulatory molecules are weakly expressed This encounter with autoreactive T cells induces anergy These resting APCs present self antigens of that tissue by this way (little or no costimulation and absent innate response)

Anergy, cont d CTLA-4 & PD-1 are inhibitory receptors on T cells they are more expressed if the cell binds to self antigens CTLA-4 binds to B7 with high affinity so when APCs present self antigens (low levels of B7) CTLA-4 is preferentially engaged microbial products elicit innate immune reactions B7 levels on APCs increase and low-affinity receptors on T cells are engaged more Polymorphisms in the CTLA4 gene are associated with some autoimmune endocrine diseases in humans

Anergy, cont d Regulatory T cells may also use CTLA-4 to suppress immune responses Some tumors and viruses may use the same pathways of immune regulation to evade immune attack antibodies are developed that block CTLA-4 and PD-1 for tumor immunotherapy

Suppression by regulatory T cells They develop mainly in the thymus, as a result of recognition of self antigens They may also be induced in peripheral lymphoid tissues The best-defined regulatory T cells: -CD4+ & expressing high levels of -CD25 (the α chain of the IL-2 receptor) -FOXP3 a transcription factor of the forkhead family

Suppression by regulatory T cells IL-2 and FOXP3 are required for the development and maintenance of functional CD4+ regulatory T cells *IPEX (an acronym for immune dysregulation, polyendocrinopathy, enteropathy, X-linked) a severe systemic autoimmune disorder *Recent studies: polymorphisms in the CD25 gene are associated with multiple sclerosis

Suppression by regulatory T cells, cont d Of Treg inhibitory activity: release of immunosuppressive cytokines Tregs also express CTLA-4 IL-10, TGF-beta, etc.

Deletion by apoptosis 2 mechanisms of inducing death in mature self-reactive T cells based on animal studies: -Expression of pro-apoptotic member of the Bcl family without anti-apoptotic members -Fas (CD95)-Fas ligand system for deleting B or T cells in mice, mutation in Fas or Fas ligand: autoimmune disease resembling SLE in human, mutations in Fas gene cause ALPS (autoimmune lymphoproliferative syndrome)

Ignorance Some antigens in certain tissues are hidden (sequestered) from the immune system no communication with the blood and lymph self antigens in these tissues are ignored by the immune system like the testis, eye and brain Immune-privileged sites because it is difficult to induce Immune responses to antigens introduced into these sites post-traumatic orchitis and uveitis

Mechanisms of autoimmunity: General principles Robbins and Cotran pathologic basis of disease 9 th edition

Role of Susceptibility Genes Most autoimmune diseases are complex multigenic disorders Among the genes known to be associated with autoimmunity, the greatest contribution is that of HLA genes Ankylosing spondylitis and HLA-B27 The mechanisms underlying these disease associations remain poorly understood Different HLA alleles may contribute to a disease but their presence is not, by itself, the cause of any disease

Role of Susceptibility Genes, cont d Association of Non-MHC Genes with Autoimmune Diseases -PTPN22 association with rheumatoid arthritis, type 1 diabetes, and several other autoimmune diseases -NOD2 and Crohn disease

Association of Non-MHC Genes with Autoimmune Diseases, cont d Polymorphisms in the genes encoding the IL-2 receptor (CD25) and IL-7 receptor α chains are associated with multiple sclerosis and other autoimmune diseases These cytokines may control the maintenance of regulatory T cells

Association of Non-MHC Genes with Autoimmune Diseases, cont d Remember: AIRE, CTLA4, PD1, FAS, FASL, and IL2 and its receptor CD25 B cells express an Fc receptor that recognizes IgG antibodies bound to antigens and switches off further antibody production (a normal negative-feedback mechanism) Knockout of this receptor results in autoimmunity, presumably because the B cells can no longer be controlled

Role of Infections Robbins and Cotran pathologic basis of disease 9 th edition